期刊文献+

PLAG1转基因小鼠中差异表达长链非编码RNA的筛选分析 被引量:1

Study on the differentially expressed long non-coding RNAs in PLAG1 transgenic mice by gene micro-array
下载PDF
导出
摘要 目的:应用基因芯片技术,筛选PLAG1转基因小鼠下颌下区多形性腺瘤中差异表达的长链非编码RNA(LncRNA)。方法:取3对PLAG1转基因小鼠下颌下区多形性腺瘤组织、对侧无瘤腺体组织、空白对照小鼠腺体组织,抽提标本总RNA并反转录合成cDNA探针,与芯片杂交后获得荧光信号,分析在肿瘤组织中差异表达的长链非编码RNA。随机挑选其中5个LncRNA,利用实时荧光定量PCR在6对样本中验证其表达。采用SPSS13.0软件包中的t检验评价表达差异。结果:基因芯片结果显示,与PLAG1转基因小鼠无瘤腺体组织、空白对照小鼠腺体组织相比,PLAG1转基因小鼠肿瘤中共有5627个LncRNA同时发生差异表达,其中2871个上调、2756个下调。实时荧光定量PCR结果显示,5个随机挑选的LncRNA中,4个(AK146794、ENSMUST00000119440、ENSMUST00000140495、Gm12873)与基因芯片结果一致。结论:应用基因芯片筛选出PLAG1转基因小鼠中差异表达的长链非编码RNA,为进一步研究多形性腺瘤的发病机制提供了依据。 PURPOSE: To screen for the differentially expressed long non-coding RNAs(LncRNAs) in pleomorphic adenoma of PLAG1 transgenic mice. METHODS: Three pairs of pleomorphic adenoma, non-tumor gland tissues from PLAG1 transgenic mice and normal gland tissues of submandibular gland from wide-type mice were collected and then the total RNA was extracted. cDNA probe was synthesized by reverse transcription and hybridized as the cDNA microarray for scanning fluorescent signals and differentially expressed LncRNAs. The expressions of 5 randomly selected LncRNAs were validated in another 6 pairs of tissues via real-time PCR. The expression differences were compared and analyzed using SPSS13.0 software package. RESULTS: Microarray results demonstrated that a total of 5627 LncRNAs(2871 upregulated and 2756 downregulated) were differentially expressed in the tumors of PLAG1 transgenic mice. Real-time PCR data showed that the expression of 4 selected LncRNAs(AK146794, ENSMUST00000119440, ENSMUST00000140495 and Gm12873) were consistent with the microarray results. CONCLUSIONS: Analysis of differentially expressed LncRNAs in PLAG1 transgenic mice can provide evidence for pathogenesis of pleomorphic adenoma.
作者 徐万林 刘丽敏 卢浩 杨雯君 沈淑坤 XU Wan-lin;LIU Li-min;LU Hao;YANG Wen-jun;SHEN Shu-kun(Department of Oromaxillofacial Head and Neck Oncology,Shanghai 200011, China;Department of Oral Pathology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology. Shanghai 200011, China)
出处 《中国口腔颌面外科杂志》 CAS 2019年第1期20-25,共6页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金青年项目(81302359) 上海市科学技术委员会研究基金项目(16ZR1418800)
关键词 基因芯片 多形性腺瘤 PLAG1转基因小鼠 长链非编码RNA Microarray Pleomorphic adenoma PLAG1 transgenic mice Long non-coding RNA
  • 相关文献

参考文献4

二级参考文献27

  • 1Kas K, Voz ML, Roijer E, et aL Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleomorphic adenomas with t(3;8)(p21;q12)translocations. Nat Genet, 1997,15 , 170-174.
  • 2Hensen K, Van Valekenborgh IC, Kas K, nal. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res, 2002, 62 , 1510-1517.
  • 3Xie W, Paterson AJ, Chin E, et al. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol,1997,11 : 1766-1781.
  • 4Palmiter RD, Brinster RL, Hammer RE, et al. Dramatic growth of mice that develop from eggs microinjected with metallothioneingrowth hormone fusion genes. 1982. Biotechnology, 1992, 24:429-433.
  • 5Voz ML, Agten NS, Van de Ven WJ, et al. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands,is a positive regulator of IGF-Ⅰ. Cancer Res, 2000,60: 106-113.
  • 6Gisselsson D, Hibbard MK, Dal Cin P, et al. PLAG1 alterations in lipoblasroma: involvement in varied mesenchymal cell types and evidence for alternative oncogenlc mechanisms. Am J Parhol,2001,159: 955-962.
  • 7Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK1/2, JNK, and p38 protein kinases[J]. Science, 2002, 298(5600): 1911-1912.
  • 8Voz ML, Mathys J, Hensen K, et al. Microarray screening for target genes of the proto-oncogene PLAG1 [J]. Oncogene, 2004, 23(1): 179-191.
  • 9Orton RJ, Sturm OE, Vyshemirsky V, et al. Computational modeling of the receptor-tyrosine-kinase-activated MAPK pathway[J]. Biochem J, 2005, 392(Pt 2): 249-261.
  • 10Hilger RA, Scheulen ME, Strumberg D. The Ras-Raf-MEK- ERK pathway in the treatment of cancer[J]. Onkologie, 2002, 25 (6): 511-518.

共引文献14

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部